Shares of Constellation Energy surged 4.8% in pre-market trading to $261.83 after the nation's largest electricity producer delivered a third-quarter earnings beat that wasn't even close. The question now: with the stock still well below its early-2026 highs, does the upgraded outlook — and a cascade of nuclear-expansion deals — justify a bigger rebound?
• A 66% Earnings Jump Shows the Calpine Deal Is Already Paying Off. Constellation reported Q3 adjusted operating earnings of $5.06 per share, up 66% year over year.
Analysts had expected just $3.73 , making this a $1.33 beat — the widest miss in estimates in recent quarters. The outperformance is driven largely by the January 2026 acquisition of Calpine Corporation for roughly $21.8 billion , which gave the combined company roughly 55 gigawatts of generation capacity and a massive retail electricity platform. The deal is doing what management promised: adding volume and diversifying revenue across nuclear, gas, and geothermal power.
• Raised Guidance Signals Management Sees No Slowdown. The company raised the midpoint and narrowed full-year adjusted earnings guidance to $12.50–$12.80 per share — the second upward revision this year , according to CFO Shane Smith. That midpoint of $12.65 sits meaningfully above where Wall Street consensus started the year, giving investors confidence that Q3 was not a one-off quarter but part of a sustained earnings ramp.
• Big Tech Contracts and a $5 Billion Government Loan Could Extend the Runway. Constellation has long-term agreements with Google and Amazon totaling more than $7 billion to add approximately 1,080 megawatts of nuclear capacity through 20-year contracts. On top of that, it secured a conditional DOE loan commitment of up to $5 billion to fund nuclear uprates — upgrades that squeeze more electricity from existing reactors — adding 1.1 gigawatts of output without building new plants. U.S. power demand is growing after decades of stagnation, fueled by AI data centers, electrification, and crypto mining.
• The Stock Is Still Cheap Relative to Analyst Targets — But Execution Risk Looms. The consensus analyst price target sits at roughly $339, a "Buy" rating , implying over 29% upside from today's price. Still, shares have fallen roughly 24% year-to-date and lagged both the S&P 500 and utilities peers.
The biggest operational risk remains nuclear policy shifts, compliance costs, and expiring Illinois clean-energy credits after 2027, which could pressure margins. Constellation has given investors a reason to re-engage — but it must now prove the Calpine integration, DOE-funded uprates, and tech-giant contracts can all deliver on schedule.